A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): Study protocol for a randomized controlled trial

José Baselga*, Frederico Costa, Henry Gomez, Clifford A. Hudis, Bernardo Rapoport, Henri Roche, Lee S. Schwartzberg, Oana Petrenciuc, Minghua Shan, William J. Gradishar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint Dive into the research topics of 'A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): Study protocol for a randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences